Background: Non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD) share common pathogenic mechanisms and many risk factors, and both are linked to an increased risk of cardiovascular diseases. The aim of this study was to assess the association between NAFLD and CKD according to the presence of hypertension and diabetes mellitus in Koreans aged 50 years or older. 
INTRODUCTION
Non-alcoholic fatty liver disease (NAFLD) is defined as fat accumulation in the liver exceeding 5% to 10% by weight and refers to a spectrum of diseases ranging from simple steatosis to steatohepatitis and cirrhosis. 1, 2) The pathological picture resembles that of alcohol-induced liver injury, but it occurs in patients who do not abuse alcohol. 3) NAFLD has emerged as a growing public health problem worldwide and is the most common cause of chronic liver disease in Western countries. 2, 4) Moreover, the presence of pathophysiological inter-relationships between the liver and the kidney is well established in humans, and is supported by the presence of hepato-renal syndrome, which may occur in patients with decompensated cirrhosis, regardless of its aetiology. 4) But there are sparse data on the relationship between NAFLD and CKD risk in apparently healthy persons. Some studies suggest that ultrasounddiagnosed NAFLD is associated, independently of several confounding factors, with a higher prevalence of CKD and retinopathy in type 1 diabetic individuals. 10) Also, NAFLD was associated with an increased CKD risk among nondiabetic, nonhypertensive Korean men. 11) However, there are few studies on the relationship between NAFLD and CKD according to the presence of hypertension and diabetes mellitus. The aim of this study was to assess the association between NAFLD and CKD according to the presence of hypertension and diabetes mellitus in Koreans aged 50 years or older.
METHODS

Study Subjects
The subjects 50 years and older were enrolled in our study because kidney diseases in older people, especially menopausal women, have generally been shown to be related with the sex hormones through the renin-angiotensin-aldosterone system. Because some individuals were excluded for multiple reasons, the total number of subjects in our study was 1,706.
Clinical Measurements and Laboratory Procedures
The health examination included a medical history, physical examination, questionnaire on health-related behavior, and anthropometric and biochemical measurements. Values are presented as mean ± SD or number (%) as assessed by t-test and chi-square test.
NAFLD: nonalcoholic fatty liver disease, HOMA-IR: homeostasis model assessment of insulin resistance.
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Hepatic ultrasonography scanning was performed in all subjects by an experienced radiologist, who was blinded to subject details and laboratory value, and was unaware of the aims of the study. 
Statistical Analysis
Statistical analysis was performed with the windows SPSS ver.
(SPSS Inc., Chicago, IL, USA). Statistical analyses included
the t-test and the chi-square test. Logistic regression analysis was used to assess the independent association of CKD with NAFLD after adjustment for potential confounders. We also performed multivariate logistic regression analysis. In the multivariate models, we included the following variables that might confound the relationship between NAFLD and CKD: age, sex, current smoking, abdominal obesity, AST, ALT, GGT, hypertension, diabetes mellitus, hypertriglyceridemia, and low HDL. 4, 7) Values at P < 0.05 were considered to be statistically significant.
RESULTS
Our study included 1,706 subjects aged 50 to 86 years.
Among the 1,706 subjects, the frequency of NAFLD and CKD was 545 (31.9%) and 424 (24.9%), respectively. The clinical characteristics stratified by the presence of NAFLD are shown in Table 1 . The subjects with NAFLD were abdominally obese, more likely to be male and had higher frequency of hypertension, diabetes mellitus, CKD, and metabolic syndrome than those without NAFLD. They also had lower HDL, higher hemoglobin A1c, fasting glucose, fasting insulin, triglyceride, and liver enzymes than those without NAFLD. 
DISCUSSION
The major finding of our study was that NAFLD is significantly associated with CKD in Koreans aged 50 years or older. After adjusting for confounding risk factors and potential confounders, such as age, sex, current smoking, abdominal obesity, AST, ALT, GGT, hypertension, diabetes mellitus, hypertriglyceridemia, and low HDL, the association between NAFLD and CKD remained statistically significant.
Recent large observational studies reported that the presence of NAFLD as detected by serum liver enzyme is strongly associated with an increased prevalence and incidence of CKD. [20] [21] [22] Several studies showed that NAFLD diagnosed by liver ultrasonography was associated with an increased prevalence of CKD in both nondiabetic and diabetic individuals. 10, 23, 24) A previous study showed that NAFLD was associated with an increased CKD risk in nonhypertensive and nondiabetic Korean men. 11) However, the population in this study included only nonhypertensive and nondiabetic young men whose mean age was 36.7 years.
Understanding the mechanisms that link NAFLD and CKD is important not only because of the societal health burden of both diseases but also because novel insights into the underlying mechanisms may lead to new strategies to prevent or treat CKD and its associated co-morbidities. However, the underlying mechanisms putatively responsible for the association between NAFLD and CKD are not fully understood. The putative underlying mechanisms that link NAFLD and CKD might originate from expanded and inflamed visceral adipose tissue.
Expanded and inflamed visceral adipose tissue releases multiple molecules that are potentially involved in the development of insulin resistance and kidney damage. 25) Insulin resistance is a key factor in the pathogenesis of NAFLD 2, 26) and also plays a role in the development of CKD. 27) There is evidence to suggesting that NAFLD may be involved in its pathogenesis, possibly through the systemic release of pathogenic mediators from the steatotic and inflamed liver, including increased reactive oxygen species, advanced glycation end products, C-reactive protein, plasminogen activator inhibitor-1, tumor necrosis factor-alpha, transforming growth factor-beta, and other proinflammatory cytokines, 28) Notably, several case control studies have shown that these plasma inflammatory, pro-coagulant, and oxidative stress factors are remarkably higher in patients with NAFLD than in those without those conditions. 29, 30) Our study has several limitations. First, the cross-sectional study design precludes the establishment of a causal relationship between NAFLD and CKD. Prospective studies will be required to sort out the time sequence of events. Second, the diagnosis of NAFLD was based on ultrasound imaging and the exclusion of other secondary causes of chronic liver disease, but was not confirmed by liver biopsy. It is known that none of the radiological features can distinguish between nonalcoholic steatohepatitis and other forms of NAFLD, and that only liver biopsy can assess the severity of damage and the prognosis. 1,2) However, liver biopsy would be impossible to perform in routine health examinations.
Moreover, liver ultrasound is the most widely used non-invasive technique to detect fatty infiltration of the liver in clinical practice. 1, 2) Third, patients with a positive result on a disptick test for proteinuria (1+ or greater) were recommended to undergo confirmation of proteinuria by measuring the albumin creatinine ratio by an untimed urine sample within 3 months, 7, 8) however, our study subjects with a positive proteinuria result had no further testing, which could have resulted in misclassification. Finally, our study subjects were selected from a population undergoing general health examination at a university medical center. Thus, Values are presented as odds ratio ± 95% confidence intervals as assessed by multivariate logistic regression analysis.
DM: diabetes mellitus.
*Adjusted for age, sex, current smoking, abdominal obesity, aspartate aminotransferase, aspartate aminotransferase, γ-glutamyltransferase, hypertriglyceridemia, and low high density lipoprotein.
